Good Doctor Cloud Healthcare Named Among China's Commercial Innovation Cases for Comprehensive Digital Empowerment of Primary Care
On August 8, the 9th China Business Innovation Conference, themed “New Commercial Journey · Innovating Toward the Future,” was held in Beijing. At the conference, the “2021–2022 China Business Innovation Development Cases” were prominently announced. Sichuan Haoyisheng Cloud Medical Technology Co., Ltd. was selected as one of the cases for its initiative titled “Comprehensive Digital Platform Empowering Primary Healthcare Across All Scenarios.”
This award is well-deserved for Haoyisheng Cloud Healthcare. The judges noted that Haoyisheng Cloud Healthcare focuses on leveraging internet big data technology and integrating online and offline services to consolidate high-quality medical resources across the industry. By comprehensively empowering primary healthcare institutions and enhancing their clinical capabilities, it has enabled the general public to truly access high-quality medical services right at their doorstep.
Empowering Grassroots Clinics Mission: Enable Primary Care Clinics to Provide Medical Services and Ensure Patients Receive High-Quality Care
In recent years, China’s “Healthy China” strategy has been advancing tiered diagnosis and treatment and enhancing the capabilities of primary healthcare institutions, with the aim of addressing challenges such as difficult and costly access to medical care. How has Haoyisheng Cloud Healthcare tackled this issue? A relevant company representative stated that Haoyisheng Cloud Healthcare positions itself as a provider of comprehensive empowerment services for primary healthcare institutions in China. It is committed to empowering these institutions across multiple dimensions, including medical laboratory testing, internet hospitals, pharmaceutical supply, and medical education. Through model innovation and leveraging internet platforms, it integrates online and offline services to deliver end-to-end solutions covering testing, diagnosis, treatment, medication, management, and medical education for primary healthcare.
As is well known, scientific diagnosis is the primary step in clinical care and the foundation of evidence-based medicine. However, primary healthcare institutions often lack the necessary testing equipment, technology, and skilled personnel, relying instead on experience-based medicine, which makes precise diagnosis a significant weakness. According to the person in charge, Haoyisheng Cloud Healthcare has launched a third-party laboratory testing platform via the “Haoyisheng Cloud Healthcare” APP, offering over 2,000 medical test items, including routine tests, genetic testing, and tumor marker assays. It also provides services such as remote dynamic electrocardiography (ECG), remote ambulatory blood pressure monitoring, and handheld remote ultrasound, enabling clinics to operate laboratory services at zero cost.To ensure the smooth implementation of laboratory services tailored to the characteristics of primary healthcare, Haoyisheng Cloud Healthcare emphasizes a physician-centric approach. It has established a professional medical team, a laboratory quality control system, and an offline service team and framework. High quality and efficiency across the entire process are ensured through five key measures: First, the selection of launched test items is designed to address the specific characteristics and pain points of primary healthcare. Second, strict process quality control is implemented to ensure the reliability of both the testing procedures and results. Third, AI-driven critical value management is applied to test results using proprietary digital technologies to prevent missed or misdiagnoses. Fourth, the medical team conducts professional analysis of high-risk critical value reports, promptly alerts and guides primary care physicians to intervene, thereby avoiding diagnostic errors and facilitating timely referrals. Fifth, comprehensive medical training is strengthened through online and offline channels, covering testing, diagnosis, and treatment, empowering primary care physicians to be willing, able, and proficient in utilizing laboratory services for effective patient care.
To date, more than 200,000 primary healthcare institutions have conducted medical laboratory tests on the Haoyisheng Cloud Medical Platform.Over 2,000 laboratory tests are offered, serving more than one million patients per month., with business operations covering nearly 30 provinces and municipalities and over 1,000 districts and counties across China.
Primary Healthcare Services Gain Another “Powerful Tool”: High-Quality Medicines Delivered to the Grassroots Level
Building on its foundation in medical laboratory testing and medical education, Haoyisheng Cloud Healthcare has made the decentralization of appropriate advanced pharmaceuticals to primary care settings a core part of its business strategy. This initiative ensures that clinics can achieve accurate diagnoses and informed treatment decisions while having access to medications with proven efficacy, thereby comprehensively empowering primary healthcare by aligning it with the standards of tiered hospitals. To this end, Haoyisheng Cloud Healthcare launched “Zhenbaobei” A in September 2021.PP, asA pharmaceutical e-commerce platform dedicated to serving clinics. Zhenbaobei tailors its offerings to the clinical pathways and medication guidelines for various diseases, while taking into account the disease spectrum, prescribing habits, and gaps in diagnosis and treatment prevalent in primary care settings. In collaboration with experts, industry organizations, and upstream manufacturers, it curates a selection of pharmaceuticals, medical devices, and herbal decoction pieces suitable for primary healthcare institutions. This helps optimize medication structures, reduce procurement costs, improve purchasing efficiency, and enhance profitability for primary care providers. As a result, “Zhenbaobei” has become the “central pharmacy” and “centralized procurement hub” for primary healthcare institutions.
To ensure the quality of this service, Haoyisheng Cloud Healthcare has launched over 15,000 SKUs and built a robust modern logistics system. This includes IT infrastructure such as ERP, WMS, and TMS systems tailored for e-commerce models; a 30,000-square-meter fully automated warehousing facility; and a distribution network combining in-house and third-party logistics to guarantee 24-hour delivery. Additionally, it has established a team of more than 2,700 professionals providing offline and online real-time customer service, platform and product operations, and medical support.
In less than a year since its launch, the platform has onboarded more than 80,000 clients and achieved a monthly gross merchandise volume (GMV) exceeding RMB 100 million. It has successfully facilitated the penetration of numerous high-quality, appropriate product portfolios from AstraZeneca, Merck, Bayer, and leading domestic pharmaceutical manufacturers into primary care settings, earning strong recognition from both primary care physicians and upstream manufacturers.
The judging panel of experts believes that the rapid development of Haoyisheng Cloud Healthcare stems from its adherence to a physician-centric approach, digital-driven operations, and the integration of online and offline services. In particular, it remains committed to its original mission of leveraging internet healthcare to empower physicians at the grassroots level who serve local communities. By grasping the essence of primary healthcare, Haoyisheng Cloud Healthcare has been able to simultaneously launch multiple business lines and services, all achieving high-speed growth and earning recognition from the industry, government, and investors.
Currently, Haoyisheng Cloud Healthcare has established significant influence among primary healthcare institutions across China. To date, it has served over 200,000 primary healthcare facilities, benefiting more than 300,000 primary care physicians through its platform. Laboratory testing services alone have catered to over 10 million patient visits.